Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$144M |
| 2 |
NVIDIA
NVDA
|
+$137M |
| 3 |
GE Aerospace
GE
|
+$129M |
| 4 |
Dell
DELL
|
+$91.3M |
| 5 |
Comcast
CMCSA
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$103M |
| 2 |
Microchip Technology
MCHP
|
+$98.3M |
| 3 |
Steel Dynamics
STLD
|
+$87M |
| 4 |
UnitedHealth
UNH
|
+$79.5M |
| 5 |
Walmart Inc
WMT
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.58% |
| 2 | Consumer Discretionary | 13.58% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Revolution Medicines
RVMD
$45.4B
| $573K | ﹤0.01% |
19,985
+10,384
| +108% | +$250K |
|
1827
United States Lime & Minerals
USLM
$3.45B
| $573K | ﹤0.01% |
+12,440
| New | +$527K |
|
1828
Celanese
CE
$4.94B
| $571K | ﹤0.01% |
3,675
+796
| +28% | +$104K |
|
1829
Peoples Bancorp
PEBO
$1.44B
| $569K | ﹤0.01% |
16,842
-1,227
| -7% | -$35.7K |
|
|
WBS
1830
DELISTED
Webster Financial
WBS
| $567K | ﹤0.01% |
+11,172
| New | +$483K |
|
1831
IDEAYA Biosciences
IDYA
$3.88B
| $565K | ﹤0.01% |
15,879
-1,205
| -7% | -$36K |
|
|
STR
1832
DELISTED
Sitio Royalties
STR
| $565K | ﹤0.01% |
24,016
-48
| -0.2% | -$1.11K |
|
1833
Sabesp
SBS
$16.3B
| $564K | ﹤0.01% |
190,848
-46,254
| -20% | -$117K |
|
1834
EyePoint Inc
EYPT
$436M
| $561K | ﹤0.01% |
24,268
+8,940
| +58% | +$99.9K |
|
1835
FuboTV Inc
FUBO
$316M
| $561K | ﹤0.01% |
14,695
+12,716
| +643% | +$440K |
|
1836
Granite Construction
GVA
$5.45B
| $557K | ﹤0.01% |
10,960
-17,347
| -61% | -$756K |
|
|
GOOD
1837
Gladstone Commercial Corp
GOOD
$636M
| $557K | ﹤0.01% |
42,081
-34,546
| -45% | -$432K |
|
1838
Delek US
DK
$4.16B
| $555K | ﹤0.01% |
21,514
-25,483
| -54% | -$674K |
|
|
SAVE
1839
DELISTED
Spirit Airlines, Inc.
SAVE
| $551K | ﹤0.01% |
33,626
-355
| -1% | -$5.11K |
|
1840
Zumiez
ZUMZ
$310M
| $550K | ﹤0.01% |
27,059
-14,904
| -36% | -$267K |
|
1841
Verra Mobility
VRRM
$676M
| $548K | ﹤0.01% |
23,807
+8,764
| +58% | +$180K |
|
1842
Ardelyx
ARDX
$973M
| $548K | ﹤0.01% |
88,318
+26,411
| +43% | +$118K |
|
1843
Myriad Genetics
MYGN
$289M
| $547K | ﹤0.01% |
28,598
-30,327
| -51% | -$525K |
|
1844
Agnico Eagle Mines
AEM
$109B
| $547K | ﹤0.01% |
9,975
-1,502
| -13% | -$75.1K |
|
|
SRTA
1845
Strata Critical Medical Inc
SRTA
$523M
| $547K | ﹤0.01% |
+154,926
| New | +$445K |
|
1846
Americold
COLD
$4.42B
| $542K | ﹤0.01% |
17,892
-12,713
| -42% | -$356K |
|
1847
Dave & Buster's
PLAY
$357M
| $541K | ﹤0.01% |
10,050
-8,566
| -46% | -$347K |
|
1848
iShares Russell 2000 ETF
IWM
$81.4B
| $536K | ﹤0.01% |
+2,669
| New | +$478K |
|
1849
Aehr Test Systems
AEHR
$3.18B
| $534K | ﹤0.01% |
20,146
+7,563
| +60% | +$221K |
|
|
NVO
1850
Novo Nordisk
NVO
$207B
| $534K | ﹤0.01% |
5,162
-133
| -3% | -$13.2K |
|
Similar funds
Cliff Asness's Q4 2023 Portfolio in Review
As of Q4 2023, Cliff Asness held 2,495 positions worth $53.1B, up 9.7% from $48.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Cliff Asness's Q4 2023 filing shows 186 new, 937 increased, 1,188 reduced and 172 closed positions. Its largest new stake was NCR Atleos: 518,383 shares worth $12.5M. The largest sale was Pfizer, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Cliff Asness's largest Q4 2023 buy was NCR Atleos: 518,383 shares worth $12.5M.
- Cliff Asness added most to Amazon in Q4 2023, an estimated $144M increase.
- Cliff Asness's biggest Q4 2023 reduction was Pfizer, cutting an estimated $103M.
- Cliff Asness fully exited Activision Blizzard in Q4 2023, selling an estimated $38.5M.
- Cliff Asness's ten largest holdings make up 15% of its $53.1B portfolio in Q4 2023.
- Cliff Asness opened 186 new positions and closed 172 in Q4 2023.
- Cliff Asness's portfolio value rose 9.7% quarter-over-quarter to $53.1B.
Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.